Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes upregulated by at least two-fold in the LAR subtype of triple negative breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
Genes downregulated by at least two-fold in the LAR subtype of triple negative breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
This set was generated using the combine tool on sets GS271621,GS271724,GS271619,GS271618,GS271617 and GS271616 and selecting genes that were unique to GS271621.
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with approved symbols if they mapped to more than one identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. If symbols mapped to more than one HGNC identifier, they were associated with HGNC identifiers that mapped to approved symbols. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes were identified by expression clustering analysis of a large number of breast cancer samples. Direction of regulation was curated from supplemental table S3B. Values represent Bonferroni corrected p-values of T-tests shown in supplemental table S3C. p-value scores were selected to be <0.05. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA
Genes upregulated by at least two-fold in the BLIA subtype of triple negative breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
Genes downregulated by at least two-fold in the BLIA subtype of breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
Genes upregulated by at least two-fold in the BLIS subtype of breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
Genes downregulated by at least two-fold in the BLIS subtype of triple negative breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
Genes upregulated by at least two-fold in the MES subtype of breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
Genes downregulated by at least two-fold in the MES subtype of triple negative breast cancer. The data is from supplemental table S37 and the values reported are the fold changes calculated from the log values reported for the Discovery Set. HGNC identifiers were mapped to gene symbols manually. Symbols were associated with HGNC identifiers that mapped to approved symbols if they mapped to more than one HGNC identifier. Symbols which were not confidently mapped were not included.
Authors:
Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH
Expression analysis was performed on laser-captured microdissected tissue. The data is taken from supplemental table 2. Gene symbols were converted to HGNC identifiers and only genes with a fold-change value of 1 (2-fold) or greater are reported. Gene values represent the false-discovery rate and only those with a value of <0.01 are reported.
Authors:
Lehmann BD, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA
Expression analysis was performed on laser-captured microdissected tissue. The data is taken from supplemental table 2. Gene symbols were converted to HGNC identifiers and only genes with a fold-change value of -1 (2-fold) or less are reported. Gene values represent the false-discovery rate and only those with a value of <0.01 are reported.
Authors:
Lehmann BD, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA
GeneWeaver